US: +1 512 898-9222
SG: +65 3138-4148
Hong Kong Medical Device Division (MDD)
Medical Device registration in Hong Kong is managed by the Medical Device Division (MDD) of the Department of Health, formerly known as the Medical Device Control Office (MDCO). The MDD is located in Taikoo Shing, Hong Kong and serves as the national regulatory body and competent authority for the country.
Over the years, several different changes have been made in order to streamline the regulatory process and ensure effective control. For instance, the MDCO introduced the Medical Device Administrative Control System (MDACS) in 1995. This electronic system facilitated the submission and processing of applications for medical device registration, import licensing, and amendment requests.
Later the MDCO was restructured and transformed into the Medical Device Division (MDD) under the Pharmacy and Poisons Board (PPB). The transition aimed to strengthen the regulation of medical devices by integrating it into the broader framework of pharmaceutical and poisons control. The MDD became the central authority responsible for licensing, registration, and surveillance of medical devices in Hong Kong.
Significant Recent Hong Kong MDD Regulatory Updates
Several regulatory updates have been made over recent years in order to ensure the Hong Kong MDD stays up to date with worldwide regulatory trends. The MDD has sought to incorporate international best practices and standards into its regulatory framework, leading to cooperation with organizations such as the International Medical Device Regulators Forum (IMDRF) and the World Health Organization (WHO) has facilitated knowledge sharing.
Another significant recent regulatory update from the MDD arrived in January 2022, the Expedited Approval Scheme. Previously a trial scheme, this regulatory update provided qualifying Class II, III, and IV applications with a quicker review process. Read more about this from our blog on the subject here.
In order to be eligible for this Expedited Approval process, the products in question must have 2 Reference Country approvals, no serious adverse events and no currently ongoing adverse events. Approved Reference Countries include the US, Canada, Europe, Australia, Japan, China, and Korea. The MDD’s formal guidance can be found here under GN-02.
Recent Blogs on Hong Kong
Hong Kong Medical Device Regulations and Important Links
More Information on Hong Kong Regulatory Requirements for Medical Devices
Come Grow With Us
Contact Asia Actual if you have any questions and/or would like to learn more about accessing the Hong Kong market specific to your product portfolio.
Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.
Latest Market Updates
US: +1 512 898-9222